Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements.
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000668404p
Ethics application status
Submitted, not yet approved
Date submitted
6/06/2025
Date registered
25/06/2025
Date last updated
25/06/2025
Date data sharing statement initially provided
25/06/2025
Type of registration
Prospectively registered

Titles & IDs
Public title
Anterior Cruciate Ligament Stratified Accelerated Repair or Reconstruction (ACL STARR Aus)
Scientific title
Anterior Cruciate Ligament Stratified Accelerated Repair or Reconstruction (ACL STARR-AUS): Single-blind randomised controlled trial for patients with proximal ACL injuries treatment with ACL Repair v ACL Reconstruction
Secondary ID [1] 314565 0
None
Universal Trial Number (UTN)
Trial acronym
ACL STARR Aus
Linked study record
The mirror UK ACL STARR trial is registered under ISRCTN24078391.

Health condition
Health condition(s) or problem(s) studied:
Anterior cruciate ligament injuries 337714 0
Condition category
Condition code
Surgery 334044 334044 0 0
Surgical techniques
Musculoskeletal 334141 334141 0 0
Other muscular and skeletal disorders
Injuries and Accidents 334142 334142 0 0
Other injuries and accidents

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
ACL Repair - is conducted with the ligament being stitched back onto the bone.
An orthopaedic surgeon will do this procedure, with surgery time anticipated to be ~1-2 hours.
Investigators will complete study-specific report forms related to the surgery which can be verified against operative reports.
Intervention code [1] 331218 0
Treatment: Surgery
Comparator / control treatment
ACL Reconstruction - is conducted by replacing the torn ACL with other tissue (e.g. hamstring graft), to act as a replacement.
An orthopaedic surgeon will do this procedure, with surgery time anticipated to be ~1-2 hours.
Investigators will complete study-specific report forms related to the surgery which can be verified against operative reports.
Control group
Active

Outcomes
Primary outcome [1] 341710 0
Knee functional outcome (self-reported)
Timepoint [1] 341710 0
24 months post-surgery
Secondary outcome [1] 448448 0
Determine the cost-effectiveness of ACL Repair compared with ACL Reconstruction from a health system perspective, in patients with recent proximal ACL ruptures
Timepoint [1] 448448 0
baseline (pre-surgery), 6, 12 & 24 months post-surgery.
Secondary outcome [2] 448449 0
Knee related emotional functioning following ACL Repair or Reconstruction surgery
Timepoint [2] 448449 0
baseline (pre-surgery), 6, 12 & 24 months post-surgery.
Secondary outcome [3] 448450 0
Surgeon confidence in the ACL surgery performed
Timepoint [3] 448450 0
day of surgery
Secondary outcome [4] 448451 0
Post-operative pain following ACL Repair and Reconstruction
Timepoint [4] 448451 0
3 and 6 weeks post-surgery
Secondary outcome [5] 448452 0
Return to activity / level of sports following ACL Repair or Reconstruction surgery and time to return to sport
Timepoint [5] 448452 0
baseline (pre-surgery), 6, 12 & 24 months post-surgery.
Secondary outcome [6] 448453 0
Patient satisfaction with the outcome of treatment following ACL Repair or Reconstruction surgery
Timepoint [6] 448453 0
12 & 24 months post-surgery
Secondary outcome [7] 448454 0
Complication profile and rate for ACL Repair and Reconstruction in the management of recent proximal ACL tears.
Timepoint [7] 448454 0
day of surgery, 6, 12, 24 months post-surgery
Secondary outcome [8] 448455 0
Evaluate outcomes related to the knee and changes to scores over time
Timepoint [8] 448455 0
6, 12 & 24 months post-surgery
Secondary outcome [9] 448456 0
Surgical complications
Timepoint [9] 448456 0
day of surgery, 6, 12, 24 months post-surgery
Secondary outcome [10] 448722 0
Return to sport
Timepoint [10] 448722 0
12 & 24 months post-surgery

Eligibility
Key inclusion criteria
1. Patients aged 14 years and above
2. Willing & able to provide informed consent and comply with study procedures
3. Proximal ACL tear pattern diagnosed by MRI suitable for both repair or reconstruction*
4. Willing to accept either study arm allocation
*A proximal tear will be diagnosed on review of the MRI scan, and eligibility will be confirmed intra-operatively on arthroscopic inspection, to confirm a Sherman Type 1 or Type 2 tear and acceptable tissue quality for repair (i.e. an intact synovial sheath surrounding the torn ACL as a single unit).
Minimum age
14 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
A patient with not be eligible for the study if ANY of the following apply:
1. History of knee major soft tissue surgery
a. Have had previous knee surgery (other than diagnostic arthroscopy or partial meniscectomy) to the index knee,
2. Concomitant severe injury to the contra-lateral knee
3. High grade multi ligament injury
a. High grade injuries to other ligaments (i.e. medial collateral, lateral collateral, posterior cruciate) in the knee (Grade >2).
4. Surgeon decision – patient not considered clinically appropriate for ACL Repair (for any reason)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
central randomisation by computer
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,QLD,SA,WA,VIC

Funding & Sponsors
Funding source category [1] 319116 0
Government body
Name [1] 319116 0
NHMRC
Country [1] 319116 0
Australia
Primary sponsor type
University
Name
University of Sydney
Address
Country
Australia
Secondary sponsor category [1] 321609 0
None
Name [1] 321609 0
Address [1] 321609 0
Country [1] 321609 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 317709 0
Sydney Local Health District Ethics Review Committee (RPAH Zone)
Ethics committee address [1] 317709 0
Ethics committee country [1] 317709 0
Australia
Date submitted for ethics approval [1] 317709 0
23/06/2025
Approval date [1] 317709 0
Ethics approval number [1] 317709 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 141890 0
Prof David Beard
Address 141890 0
NHMRC Clinical Trials Centre (CTC), Level 6, Lifehouse, 119-143 Missenden Rd, Camperdown NSW 2050
Country 141890 0
Australia
Phone 141890 0
+61 2 9562 5000
Fax 141890 0
Email 141890 0
Contact person for public queries
Name 141891 0
Ms Clare Toms
Address 141891 0
NHMRC Clinical Trials Centre (CTC), Level 6, Lifehouse, 119-143 Missenden Rd, Camperdown NSW 2050
Country 141891 0
Australia
Phone 141891 0
+61 2 9562 5000
Fax 141891 0
Email 141891 0
Contact person for scientific queries
Name 141892 0
David Beard
Address 141892 0
NHMRC Clinical Trials Centre (CTC), Level 6, Lifehouse, 119-143 Missenden Rd, Camperdown NSW 2050
Country 141892 0
Australia
Phone 141892 0
+61 2 9562 5000
Fax 141892 0
Email 141892 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.